Transient Receptor Potential Melastatin 4 (TRPM4) is associated with an immuno-stimulatory TME and better prognosis in BLCA
Abstract Objective Bladder cancer (BLCA) is one of the most invasive and malignant tumors in the world, thus leading to the urgent need of an accurate and recognizable biomarker. Several previous research has shown that Transient Receptor Potential Melastatin 4 (TRPM4) plays an important role in mea...
Zapisane w:
| Główni autorzy: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Springer
2025-11-01
|
| Seria: | Discover Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1007/s12672-025-04080-z |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|